Spontaneous neoplasm rates were determined for control Fischer 344 (F344) rats and B6C3Fl mice from 2-yr rodent carcinogenicity studies carried out by the National Toxicology Program (NTP). The most frequently occurring neoplasms in untreated male F344 rats were testicular adenoma (89. I 56). mononuclear cell leukemia (50.5%), adrenal gland pheochromocytoma (3 1.9%). and pituitary gland neoplasms (30.4%). For untreated female F344 rats, the most frequently occurring neoplasms were pituitary gland neoplasms (54.2%). mammary gland fibrondenoma (41.2%). and mononuclear cell leukemia (28.1 8). The most frequently occurring neoplasms in untreated male B6C3Fl mice were liver adenomdcarcinoma (42.2%). lung adenomdcarcinoma (20.5%), and malignant lymphoma (8.3%). For untreated female B6C3F, mice, the most frequently occurring neoplasms were liver adcnomdcarcinomn (23.68). malignant lymphoma (20.9%). and pituitary gland adenomdcarcinoma (14.8%). The tumor rates observed in feeding study (untreated) and inhalation study (chamber) control rats were generally similar. The major exceptions were pituitary gland tumors and testicular adenoma in male F344 rats. The overall incidence of testicular adenoma was much lower in chamber controls (69.4%) than in feeding study controls (89.1%). whereas pituitary gland neoplasms showed the opposite trend (60.7% vs 30.4%). The most likely explanation for this difference is related to the individual housing of chamber controls and the group housing of feeding study controls. Differences in diagnostic criteria may influence reported tumor rates. To ensure consistency and comparability of tumor diagnosis from study to study, the NTP uses rigorous histopathology quality assurance and peer review procedures. Biological factors such as body weight may also affect tumor incidence. For example, increased body weights are associated with increased incidences of certain site-specific neoplasms, espccially pituitary gland and mammary gland neoplasms in rats and liver tumors in mice. The presence of Helicobacter hepporicrrs has been associated with an increased incidence of liver neoplasms in male B6C3FI mice. Other factors that may produce differences in control tumor rates from study to study include diet, environmental factors. genetic drift. study duration. and survival differences. The NTP database provides historical control data that may b e useful j n the evaluation of possible chemically related changes in tumor incidence. However, it is essential that the study being evaluated be comparable to those in the NTP database with respect to those factors that are known to influence tumor occurrence.
INTRODUCTION
During the past decade the National Toxicology Program (NTP) has established, developed, and maintained 1 of the world's largest historical control databases for neoplasms of the Fisher 344 (F344) rat and B6C3F, mouse. This information is useful in the interpretation of experimental results from similar studies, especially for rare neoplasms and for borderline effects (12) . A comprehensive in-life database of survival and body weight data from NTP studies is also available.
The most appropriate and important comparison of an experimental group is with its concurrent control (7, 11, 39) . However, there are specific instances in which historical control rates provide relevant data needed to interpret results of rodent carcinogenicity studies. For example, the evaluation of rare neoplasms may require less stringent statistical evidence in a given study if the low spontaneous rate can be demonstrated from an established historical control database (8) . Historical control data may also be helpful in the evaluation of a neoplasm showing a marginal increase in incidence relative to concurrent controls (39). In these cases, consideration of historical control data is useful in deciding whether or not the apparent increase in neoplasm incidence is a biologically meaningful effect. Historical control data may also be useful from a quality control point of view, to help determine if concurrent control neoplasm rates are consistent with past experience (1 1) .
There have been a number of previous tabulations of control tumor incidence in F344 rats and B6C3FI mice from long term carcinogenicity studies (5, 9, 14, 17, 18, 37, 38, 42, 45) . The purpose of this paper is to update these control tumor rates and to discuss the factors that may have produced changes in spontaneous neoplasm rates over time.
The historical control database summarized in this paper includes NTP studies whose pathology evaluation had been finalized and entered on the Toxicology Data Management System as of January 1, 1997 . Separate tabulations are presented for control groups associated with the 2 most common routes of chemical administration: untreated controls from 27 feeding studies and chamber controls from 18 (rats) or 21 (mice) inhalation studies. All animals in these studies were fed ad libitrm the NIH07 diet (33) .
A possible limitation of this database, particularly relative to the categorization of neoplasms of mesenchymal origin, is that in most instances a diagnosis is based on evaluation of a single hematoxylin and eosin-stained section without the use of additional special stains or specific tumor/cell type markers. The diagnostic criteria used in these studies are consistent with those used for previous NTP neoplasm databases (14) .
The procedures used to validate neoplasm incidences in these studies include a multistage quality assurance procedure to verify and assure that the pathology data are consistent and accurate (4, 10). In the first stage, the neoplasm incidence summaries are reviewed for consistency and proper terminology at the testing laboratory. In the second stage, the quality of the pathology specimens (formalin-fixed tissues, paraffin blocks, and microscopic slides) are reviewed for completeness. During the third stage, a review of morphologic diagnosis is conducted by an independent pathologist, who prepares a quality assessment report documenting any diagnostic discrepancies. These discrepancies are then resolved by a Pathology Working Group (PWG).
The PWG is a panel of pathologists from academia, industry, and government who are selected because of their expertise in rodent toxicologic pathology or because of their expertise in the issues to be resolved (3, 46) . The pathologists in the PWG record their diagnoses separately. Consensus diagnoses are then reached by vote and/or discussion. Original diagnoses that differ from the consensus are changed. The PWG procedure assures that the pathology diagnoses and interpretations meet current standards being used by the NTP for rodent toxicology and carcinogenesis studies.
The sources of animals for most of the NTP studies summarized here were Frederick Cancer Research Facility (Frederick, MD), Taconic Farms (Germantown, NY), and Simonson Laboratories (Gilroy, CA). Most inhalation studies were carried out at Battelle Pacific Northwest Laboratories (Richland, WA). The 3 laboratories used most often for NTP feeding studies were Battelle Columbus (Columbus, OH), E. G. & G. Mason Research Institute (Worcester, MA), and Southern Research Institute (Birmingham, AL).
Statistical evaluation of the data included analysis of variance procedures to assess the effect of route of administration and sex differences on 2-yr survival and body weight and Mann-Whitney U-tests to make pairwise comparisons of site-specific tumor incidence in chamber and feeding study control groups (36). Tables I and 11 summarize neoplasm rates for studies in the NTP historical control database for F344 rats and B6C3F, mice, respectively. For each type of neoplasm (and for all sites and types of neoplasms combined), these tables give the proportion of tumor-bearing animals and the range of neoplasm rates found among control groups. Reported rates are for all animals in the 2-yr study and are not limited to animals surviving until euthanasia at the conclusion of the study.
-

RESULTS
The most frequently occurring neoplasms in untreated male F344 rats were testicular adenoma (89.1%), mononuclear cell leukemia (50.5%), adrenal gland pheochromocytoma (3 1.9%), pituitary gland neoplasms (30.4%), thyroid gland c-cell neoplasms (14.5%), and preputial gland neoplasms (10.6%). For untreated female F344 rats, the most frequently occurring neoplasms were pituitary gland neoplasms (54.2%), mammary gland fibroadenoma (4 1.2%), mononuclear cell leukemia (28.1 %), uterine strornal polyps (14.2%), thyroid c-cell neoplasms (13.5%), and clitoral gland neoplasms (12.0%). Approximately 96% of all untreated male and female F344 rats had some type of neoplasm, and 64% of the males and 43% of the females had at least 1 malignant neoplasm ( Table I) .
The most frequently occurring neoplasms in untreated male B6C3F1 mice were liver adenoma/carcinoma (42.2%), lung adenomdcarcinoma (20.5%), malignant lymphoma (8.3%), hemangioma/hemangiosarcoma (5.9%), and harderian gland neoplasms (5.4%). For untreated 'female B6C3F, mice, the most frequently occur-.ring neoplasms were liver adenoma/carcinoma (23.6%). malignant lymphoma (20.9%); pituitary. gland adenomd carcinoma (14.8%), lung adenomdcarcinoma (8.1%), hemangiomahemangiosarcoma (4.3%), and harderian gland neoplasms (4.0%). More than two-thirds of untreated male and female B6C3F, mice had some type of neoplasm, and approximately 39% had at least 1 malignant neoplasm (Table 11) .
Two-year survival rates in control animals are summarized in Table 111 . Analysis of variance reveals that (a) B6C3F, mice survive significantly longer (p < 0.05) than F344 rats, (b) untreated controls from feeding studies survive significantly longer (p C 0.05) than chamber controls from inhalation studies, and (c) female rats survive significantly longer (p < 0.05) than male rats, but there is no significant sex difference in survival for mice.
Body weight comparisons are also given in Table 111 . For male rats, body weights were significantly greater (p < 0.05) in chamber controls than in the feeding study controls, which may have been a contributing factor to the lower survival in the former group. Feeding study and chamber control female rats had similar body weights, whereas for mice, feeding study controls were slightly but significantly heavier overall (p < 0.05) than chamber controls, as determined by analysis of variance ( Table 111) .
Comparisons of neoplasm rates between feeding study and chamber controls showed some notable differences in F344 rats but not in B6C3F1 mice. For male rats, the 28.1 14-52 ( * p C 0.05 vs. feeding study controls.
overall incidence of testicular adenoma was much lower in chamber controls (69.4%) than in feeding study controls (89.1 %), whereas pituitary gland neoplasms showed the opposite trend (60.7% vs 30.4%). Female rats showed a significantly elevated (p < 0.05) rate of pituitary gland neoplasms (62.9% vs 54.2%) and leukemia (37.3% vs 28.1%) in the chamber controls relative to the feeding study controls. Male and female mice showed no remarkable differences in the incidence of neoplasms between these 2 types of control groups. DISCUSSION Control F344 rats in NTP long-term rodent carcinogenicity studies have shown a time-related increase in body weight and a corresponding decrease in suryival (12, 20, 32, 40) . More recently, B6C3F, mice have shown a similar trend (1 1, 15) . The major reason for this gradual increase in body weight may be related to the selection of breeding stock for faster growth and earlier reproduction to satisfy user preference for larger rodents at low cost (30) . Increasing body weights and decreasing control survival have also been reported for Sprague-Dawley rats (23) and seem to be present in many other commercially available rat strains (23, 24, 28) .
The reduction in 2-yr survival for male F344 rats in particular has been quite striking. A decade ago, the average 2-yr survival of untreated male F344 rats was 66% (18); the survival rate has now fallen to -60% (Table   111 ). The major causes of death in male F344 rats are leukemia, pituitary gland neoplasms, and severe nephropathy (16), all of which have been increasing in incidence in the more recent control groups (16, 30, 32) .
Many spontaneous tumor rates have increased relative to previous reports. In some cases, increasing body weights can account for much of these increases. For example, a comparison of current feeding study control tumor rates with those previously reported (18) reveals that the neoplasms with the greatest increase in incidence are mononuclear cell leukemia in male (27% vs 51%) and female (18% vs 28%) rats, liver tumors in male (30% vs 42%) and female (8% vs 24%) mice, and mammary gland tumors in female rats (28% vs 41%). With the exception of leukemia, these are also the specific neoplasms most strongly associated with body weight (12, 15, 34, 35) . Table IV illustrates the association between liver neoplasm incidence and body weight in feeding study and chamber control B6C3F, mice. To some extent, the increasing liver tumor rates in control B6C3F, mice are related to an NTP protocol change from group to individual housing of mice, which resulted in substantially elevated body weights in the individually housed animals (15).
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Housing protocols can also account for certain differences in tumor incidence in F344 rats. For example, F344 rats are individually housed in inhalation studies but are group housed in feeding studies. This difference in housing protocol may explain the increased incidence of pi--. . tuitay gland neoplasms and the decreased incidence of testicular adenoma in chamber control male rats relative to feeding study controls. One hypothesis to account for this difference is that stress related to individual housing directly impairs testosterone synthesis and produces Leydig cell atrophy, which leads to a feedback increase in the synthesis of lutehizing hormone by the anterior pituitary. This increase in hormone production is followed by anterior pituitary cell functional hypertrophy, hyperplasia, and eventually neoplasia. Stress produced by individual housing is also known to be associated with increased serum corticosteroids. The testicular interstitial cells (Leydig cells) have specific receptors for the glucocorticoid hormones. Prolonged stress depletes the Leydig cell enzyme that inactivates glucocorticoids, enabling the glucocorticoids to impair steroidogenesis and eventually leading to compensatory pituitary proliferations, including neoplasms (27) .
Although most neoplasms in F344 rats and B6C3F, mice have shown increased control incidences relative to previously reported rates, there are exceptions. For example, when compared with the neoplasm rates in untreated controls reported a decade ago (18), there has actually been a slight decrease in the control incidences of endometrial stromal uterine polyps in female rats (22% vs 14%) and malignant lymphoma in male (12% vs 8%) and female (27% vs 21%) mice. The reasons for these slight decreases are unknown.
Recently, there. has been increased interest in dietary restriction or dietary control as a means of reducing body weight and improving survival (2, [22] [23] [24] 41) . Studies in F344 rats and B6C3Fl mice carried out under these protocols will likely have control neoplasm rates that are reduced, perhaps substantially, relative to those given in Tables I and 11 ; neoplasm rates were reduced for feedrestricted controls in the recently completed NTP Dietary Restriction Study (1, 13) . Thus, if the neoplasm rates summarized in Tables I and I1 are to be used as meaningful historical control data in the evaluation of possible carcinogenic effects in a given study, the body weights in that study should be similar to those of the control animals in the database (see Table 111 ).
Corn oil gavage is another factor that can influence tumor incidence. For example, previous studies have shown that corn oil gavage control male rats have a much higher incidence of pancreatic acinar cell neoplasms and a much lower incidence of mononuclear cell leukemia than untreated controls (18, 20, 25, 31) . For the latest NTP corn oil gavage controls, the rates of mononuclear cell leukemia and pancreatic acinar cell neoplasms in male F344 rats were 26.2% (202/772) and 7.9% (60/763), respectively. These rates continue to be different from those of feeding study and chamber controls (see Table  1 ).
Another factor that can affect tumor incidence is the presence of infectious organisms, such as Helicobncter hepaticus, which has been associated with an increased incidence of liver neoplasms in male B6C3Fl mice (43, 44) . Although 9 NTP studies have shown definitive evidence of this infection (26) , only l , involving cobalt sulfate heptahydrate, is part of the database summarized in -_.
Tables I and I1 (26) . The incidence of liver neoplasms in chamber control male mice in this inhalation study was high (76%) and outside the range found in other contemporary chamber control groups (1 1-70%). Four heptoblastomas, 1 hepatocholangiocarcinoma, and 2 liver hemangiosarcomas were also observed in this control group; these data were excluded from Table 11 . The incidences of liver neoplasms in female mice were not significantly increased in studies affected by H. hepaticiis infection (43, 44) , and the control incidence of liver adenomdcarcinoma in female mice in the cobalt sulfate heptahydrate study (36%) was well within the control range (3-56%) determined from contemporary inhalation studies; thus, these data were included in Table 11 .
Target organ toxicity also may influence tumor incidence. For example, in a recent evaluation of the NTP database, 13 of 14 chemicals associated with striking decreases in mononuclear cell leukemia in male and female F344 rats also produced splenic toxicity in the 13-wk studies (6). Other factors that may produce differences in control neoplasm rates from study to study include diet, environment, genetic drift, study duration, and survival differences (15, 19) .
To date, many statistical procedures have been proposed for incorporating historical control data into a statistical analysis of possible chemically related carcinogenic effects (12, 21, 29) . Any statistical methodology that uses historical control data should take into account study-to-study variability in tumor incidence and survival differences. Various techniques have been proposed for this purpose, but no method has been universally accepted as best. Such procedures may be most valuable for .rare tumors because the relatively infrequent tumor occurrences minimize the problems associated with studyto-study variability.
No formal statistical analyses using historical control data are generally carried out by the NTP because of concerns regarding the comparability of earlier studies with the concurrent controls. However, in each NTP technical report, historical control information, such as that summarized in Tables I and 11 , is provided for all tumors showing evidence of chemically related effects, and this information is frequently used in the overall interpretation of the data.
The NTP database summarized here provides historical control data that may be useful in the evaluation of possible chemically related changes in tumor incidence. However, the study being evaluated must be comparable to those in the NTP database with respect to factors known to influence tumor occurrence.
